Clorox (CLX)
Market Price (3/5/2026): $117.47 | Market Cap: $14.3 BilSector: Consumer Staples | Industry: Household Products
Clorox (CLX)
Market Price (3/5/2026): $117.47Market Cap: $14.3 BilSector: Consumer StaplesIndustry: Household Products
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, Dividend Yield is 2.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.0%, FCF Yield is 5.4% | Weak multi-year price returns2Y Excs Rtn is -53%, 3Y Excs Rtn is -88% | Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -5.7%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.4%, Rev Chg QQuarterly Revenue Change % is -0.8% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 12% | Key risksCLX key risks include [1] significant operational disruption and financial impact from its major ERP system transition and [2] widespread business interruption stemming from a recent cyberattack. | |
| Low stock price volatilityVol 12M is 23% | ||
| Megatrend and thematic driversMegatrends include Health & Wellness Trends, and Sustainable Consumption. Themes include Nutritional Supplements, Organic & Natural Products, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.4%, Dividend Yield is 2.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.0%, FCF Yield is 5.4% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 12% |
| Low stock price volatilityVol 12M is 23% |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends, and Sustainable Consumption. Themes include Nutritional Supplements, Organic & Natural Products, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -53%, 3Y Excs Rtn is -88% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -5.7%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.4%, Rev Chg QQuarterly Revenue Change % is -0.8% |
| Key risksCLX key risks include [1] significant operational disruption and financial impact from its major ERP system transition and [2] widespread business interruption stemming from a recent cyberattack. |
Qualitative Assessment
AI Analysis | Feedback
Clorox (CLX) stock has gained about 10% since 11/30/2025 because of the following key factors:
1. Easing of ERP Transition Headwinds and Sequential Improvement in Sales Performance. The significant operational challenges from Clorox's ERP system transition, which led to a 19% decrease in net sales in Q1 fiscal year 2026 (reported November 3, 2025), showed substantial signs of easing. By Q2 fiscal year 2026 (reported February 3, 2026), net sales decreased by only 1%, with organic sales also declining by 1%. This marked a notable sequential improvement, suggesting that the most severe disruptions were likely behind the company and a path to recovery was becoming clearer to investors.
2. Confirmation of Fiscal Year 2026 Outlook and Anticipated Back-Half Recovery. Despite a slight miss on Q2 fiscal year 2026 earnings per share, Clorox confirmed its full fiscal year 2026 outlook. Management reiterated expectations for a return to positive low single-digit organic sales growth and anticipated robust gross margin expansion in the second half of the fiscal year. This forward-looking guidance likely reassured investors about the company's future performance and ability to rebound from recent challenges.
Show more
1. Easing of ERP Transition Headwinds and Sequential Improvement in Sales Performance. The significant operational challenges from Clorox's ERP system transition, which led to a 19% decrease in net sales in Q1 fiscal year 2026 (reported November 3, 2025), showed substantial signs of easing. By Q2 fiscal year 2026 (reported February 3, 2026), net sales decreased by only 1%, with organic sales also declining by 1%. This marked a notable sequential improvement, suggesting that the most severe disruptions were likely behind the company and a path to recovery was becoming clearer to investors.
2. Confirmation of Fiscal Year 2026 Outlook and Anticipated Back-Half Recovery. Despite a slight miss on Q2 fiscal year 2026 earnings per share, Clorox confirmed its full fiscal year 2026 outlook. Management reiterated expectations for a return to positive low single-digit organic sales growth and anticipated robust gross margin expansion in the second half of the fiscal year. This forward-looking guidance likely reassured investors about the company's future performance and ability to rebound from recent challenges.
Show more
Stock Movement Drivers
Fundamental Drivers
The 10.0% change in CLX stock from 11/30/2025 to 3/4/2026 was primarily driven by a 14.3% change in the company's P/E Multiple.| (LTM values as of) | 11302025 | 3042026 | Change |
|---|---|---|---|
| Stock Price ($) | 106.76 | 117.43 | 10.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 6,771 | 6,758 | -0.2% |
| Net Income Margin (%) | 11.7% | 11.2% | -4.4% |
| P/E Multiple | 16.6 | 18.9 | 14.3% |
| Shares Outstanding (Mil) | 123 | 122 | 0.8% |
| Cumulative Contribution | 10.0% |
Market Drivers
11/30/2025 to 3/4/2026| Return | Correlation | |
|---|---|---|
| CLX | 10.0% | |
| Market (SPY) | 0.3% | -1.8% |
| Sector (XLP) | 9.8% | 66.3% |
Fundamental Drivers
The 1.5% change in CLX stock from 8/31/2025 to 3/4/2026 was primarily driven by a 7.5% change in the company's P/E Multiple.| (LTM values as of) | 8312025 | 3042026 | Change |
|---|---|---|---|
| Stock Price ($) | 115.70 | 117.43 | 1.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,104 | 6,758 | -4.9% |
| Net Income Margin (%) | 11.4% | 11.2% | -2.0% |
| P/E Multiple | 17.6 | 18.9 | 7.5% |
| Shares Outstanding (Mil) | 123 | 122 | 1.3% |
| Cumulative Contribution | 1.5% |
Market Drivers
8/31/2025 to 3/4/2026| Return | Correlation | |
|---|---|---|
| CLX | 1.5% | |
| Market (SPY) | 6.5% | -1.0% |
| Sector (XLP) | 8.6% | 63.4% |
Fundamental Drivers
The -21.8% change in CLX stock from 2/28/2025 to 3/4/2026 was primarily driven by a -53.5% change in the company's P/E Multiple.| (LTM values as of) | 2282025 | 3042026 | Change |
|---|---|---|---|
| Stock Price ($) | 150.23 | 117.43 | -21.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,165 | 6,758 | -5.7% |
| Net Income Margin (%) | 6.4% | 11.2% | 75.2% |
| P/E Multiple | 40.7 | 18.9 | -53.5% |
| Shares Outstanding (Mil) | 124 | 122 | 1.8% |
| Cumulative Contribution | -21.8% |
Market Drivers
2/28/2025 to 3/4/2026| Return | Correlation | |
|---|---|---|
| CLX | -21.8% | |
| Market (SPY) | 16.3% | 21.2% |
| Sector (XLP) | 6.9% | 64.6% |
Fundamental Drivers
The -16.1% change in CLX stock from 2/28/2023 to 3/4/2026 was primarily driven by a -52.4% change in the company's P/E Multiple.| (LTM values as of) | 2282023 | 3042026 | Change |
|---|---|---|---|
| Stock Price ($) | 139.91 | 117.43 | -16.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,065 | 6,758 | -4.3% |
| Net Income Margin (%) | 6.2% | 11.2% | 81.4% |
| P/E Multiple | 39.7 | 18.9 | -52.4% |
| Shares Outstanding (Mil) | 124 | 122 | 1.6% |
| Cumulative Contribution | -16.1% |
Market Drivers
2/28/2023 to 3/4/2026| Return | Correlation | |
|---|---|---|
| CLX | -16.1% | |
| Market (SPY) | 79.3% | 15.4% |
| Sector (XLP) | 30.2% | 56.6% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CLX Return | -11% | -17% | 5% | 18% | -36% | 21% | -29% |
| Peers Return | 12% | -14% | 11% | 15% | -10% | 15% | 28% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -0% | 81% |
Monthly Win Rates [3] | |||||||
| CLX Win Rate | 42% | 50% | 58% | 50% | 17% | 67% | |
| Peers Win Rate | 53% | 38% | 52% | 63% | 35% | 60% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| CLX Max Drawdown | -20% | -29% | -15% | -9% | -38% | -0% | |
| Peers Max Drawdown | -9% | -27% | -7% | -1% | -15% | -2% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: PG, CL, KMB, CHD, ECL. See CLX Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/4/2026 (YTD)
How Low Can It Go
| Event | CLX | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -48.1% | -25.4% |
| % Gain to Breakeven | 92.6% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -18.0% | -33.9% |
| % Gain to Breakeven | 22.0% | 51.3% |
| Time to Breakeven | Not Fully Recovered days | 148 days |
| 2018 Correction | ||
| % Loss | -23.3% | -19.8% |
| % Gain to Breakeven | 30.4% | 24.7% |
| Time to Breakeven | 136 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -33.0% | -56.8% |
| % Gain to Breakeven | 49.2% | 131.3% |
| Time to Breakeven | 583 days | 1,480 days |
Compare to PG, CL, KMB, CHD, ECL
In The Past
Clorox's stock fell -48.1% during the 2022 Inflation Shock from a high on 1/27/2021. A -48.1% loss requires a 92.6% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Clorox (CLX)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States. The Household segment provides cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; bags and wraps under the Glad brand name; and grilling products under the Kingsford and Kingsford Match Light brand names in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand name; natural personal care products under the Burt's Bees brand name; and water-filtration systems and filters under the Brita brand name in the United States. The International segment provides laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brand names. The Clorox Company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.
AI Analysis | Feedback
Here are 1-3 brief analogies for Clorox:
- The Procter & Gamble of household cleaning, charcoal, and pet care products.
- Like Unilever, but specializing in brands ranging from Clorox bleach to Burt's Bees and Glad bags.
AI Analysis | Feedback
- Clorox Bleach & Cleaning Products: Disinfecting bleaches, wipes, and sprays used for household cleaning and sanitation.
- Pine-Sol: Multi-surface cleaners known for their distinctive scent and ability to tackle tough messes.
- Glad: Plastic bags, wraps, and containers for food storage, trash management, and general household use.
- Kingsford: Charcoal briquets and grilling accessories primarily used for outdoor cooking.
- Hidden Valley Ranch: Salad dressings, dips, and seasoning mixes, most famously the original ranch flavor.
- Fresh Step: Cat litter products designed to control odors and provide a comfortable environment for pets.
- Brita: Water filtration systems, including pitchers, dispensers, and faucet filters, to improve tap water quality.
- Burt's Bees: Natural personal care products, such as lip balms, skincare, and bath products.
AI Analysis | Feedback
Clorox (CLX) sells primarily to other companies, specifically major retail chains and e-commerce platforms that distribute its products to individual consumers.
According to its most recent annual filings, Clorox's major customers are:
- Walmart Inc. (Symbol: WMT)
- The Kroger Co. (Symbol: KR)
- Amazon.com, Inc. (Symbol: AMZN)
AI Analysis | Feedback
nullAI Analysis | Feedback
Linda Rendle, Chair and CEO
Linda Rendle was named CEO of The Clorox Company in September 2020 and added responsibilities as chair of the board in January 2024. She has been with Clorox for over 20 years, holding various senior leadership positions. Prior to becoming CEO, she served as president, overseeing all of the company's businesses, corporate and business development, corporate strategy, and five core global functions. Her roles at Clorox have also included executive vice president – Cleaning, International, Strategy and Operations, and vice president and general manager – Home Care. Before joining Clorox in 2003, Rendle worked for The Procter & Gamble Company in sales management.
Luc Bellet, Executive Vice President and Chief Financial Officer
Luc Bellet was appointed Executive Vice President and Chief Financial Officer of The Clorox Company, effective April 1, 2025. He has been with Clorox for over 18 years, most recently serving as the company's treasurer. Bellet has held various leadership roles across Clorox's financial organization, including financial planning and analysis, internal audit, and business development.
Nina Barton, Executive Vice President and Group President – Care & Connection
Nina Barton is the Executive Vice President and Group President – Care & Connection at Clorox.
Angela Hilt, Executive Vice President and Chief Legal and External Affairs Officer and Corporate Secretary
Angela Hilt serves as Executive Vice President and Chief Legal and External Affairs Officer and Corporate Secretary for The Clorox Company.
Chris Hyder, Executive Vice President and Group President — Health & Hygiene
Chris Hyder is the Executive Vice President and Group President — Health & Hygiene at Clorox.
AI Analysis | Feedback
The Clorox Company (CLX) faces several key risks to its business operations and financial performance.Key Risks to Clorox (CLX)
- Operational Disruptions from ERP Transition and Cyberattack: Clorox is experiencing significant operational challenges stemming from a major Enterprise Resource Planning (ERP) system transition in the U.S. This transition is projected to cause a 7% to 8% decline in year-over-year sales and reduce fiscal year 2026 earnings per share by $0.85 to $0.95. This operational "hangover" is leading to short-term volatility in financial reports and an inventory drawdown. Further compounding operational risks, Clorox experienced a cyberattack in August 2023 that resulted in widespread disruption to its IT systems. This incident necessitated manual order processing, temporary shutdowns of some operations, and product shortages, materially impacting its fiscal first-quarter financial performance.
- Intense Competition and Shifting Consumer Preferences: Clorox operates within a highly competitive market against major players such as Procter & Gamble, Kimberly-Clark, and Unilever. This competitive environment can lead to price wars, reduced profit margins, and a potential loss of market share. Additionally, macroeconomic uncertainty is driving consumers to be more value-seeking, leading to shifts in purchasing channels and sluggish growth in certain product categories, including trash bags and cat litter. The increasing threat of private label brands also intensifies competitive pressure.
- Inflationary Pressures and Tariffs: The company continues to navigate ongoing external cost pressures, with inflationary pressures directly impacting its gross margins. Furthermore, Clorox faces an estimated annual impact of $100 million due to tariffs on its cost of goods sold, presenting a significant challenge to its profitability. While management is implementing strategies like recalibrated promotions and cost-saving measures, the persistent nature of these tariffs remains a continuous hurdle.
AI Analysis | Feedback
The rapid growth of direct-to-consumer (DTC) and subscription-based brands specializing in eco-friendly, refillable, and plant-based cleaning and household products, which are capturing market share by appealing to evolving consumer preferences for sustainability and convenience.
AI Analysis | Feedback
Addressable Market Sizes for Clorox's Main Products:
-
Household Cleaning Products (e.g., Clorox Disinfecting Wipes, Clorox Bleach):
- Global Household Cleaning Products Market: USD 270.36 billion in 2024, projected to reach USD 379.76 billion by 2032.
- U.S. Household Cleaning Products Market: Projected to reach an estimated value of USD 85.22 billion by 2032.
- Global Wipes Market: Valued at USD 4.86 billion in 2024, projected to reach USD 8.04 billion by 2032.
- U.S. Wet Wipes Market: Generated USD 6,954.3 million in 2022 and is expected to reach USD 8,542.5 million by 2030.
- Global Bleaching Agents Market: Estimated at USD 887.7 million in 2022 and projected to reach USD 1,350.1 million by 2030.
-
Cat Litter Products (e.g., Fresh Step, Scoop Away):
- Global Cat Litter Products Market: Estimated at USD 16.41 billion in 2024 and projected to reach USD 22.31 billion by 2030.
- U.S. Cat Litter Products Market: Estimated at USD 4.53 billion in 2024 and projected to reach USD 5.74 billion by 2030.
-
Grilling Charcoal (e.g., Kingsford):
- Global BBQ Charcoal Market: Stood at US$ 3.25 billion in 2023, projected to reach US$ 5.24 billion by 2033.
- North America BBQ Charcoal Market: Accounted for approximately 48% market share in 2021.
-
Water Filtration Products (e.g., Brita):
- Global Water Purifier Market: Valued at USD 35.01 billion in 2024, projected to grow to USD 62.88 billion by 2032.
- U.S. Water Purifier Market: Projected to reach an estimated value of USD 10.63 billion by 2032.
- Global Home Water Filtration Unit Market: Valued at USD 12.12 billion in 2022 and projected to reach USD 26.73 billion by 2030.
-
Natural Personal Care Products (e.g., Burt's Bees):
- Global Natural and Organic Personal Care Market: Generated a revenue of US$ 28.4 billion in 2025, projected to top US$ 54.3 billion by 2032.
- U.S. Natural and Organic Personal Care Market: Projected to be worth US$ 2,222.2 million (US$ 2.22 billion) in 2024.
-
Insect Repellents (e.g., Repel, STEM):
- Global Insect Repellent Market: Estimated at USD 5.57 billion in 2024 and projected to reach USD 8.28 billion by 2030.
- U.S. Insect Repellent Market: Generated a revenue of USD 376.9 million in 2024 and is expected to reach USD 540.6 million by 2030.
-
Food Bags and Wraps (e.g., Glad):
- null
AI Analysis | Feedback
The Clorox Company (CLX) is expected to drive future revenue growth over the next 2-3 years through several strategic initiatives:-
Product Innovation and New Launches: Clorox plans to introduce new innovations across its major brands, including Glad, Brita, and Burt's Bees, with further product developments anticipated in the latter half of fiscal year 2026 to maintain competitiveness and drive growth. Analysts also note that upcoming product innovation, particularly in premium and wellness platforms, aims to regain market share and foster organic growth.
-
Strategic Pricing and Margin Management: The company is leveraging disciplined pricing actions and a comprehensive margin-management program to support growth and mitigate cost pressures. Clorox's multi-faceted pricing policy includes premium pricing for core brands and strategic adjustments in categories supported by value and innovation.
-
Digital Transformation and ERP System Benefits: The successful launch of a new ERP (Enterprise Resource Planning) system in the U.S. is a critical enhancement to Clorox's digital infrastructure. This system is expected to unlock new value streams, strengthen operational capabilities, improve efficiency, and drive sustained margin gains over the next several years.
-
Reinvigorating Category Growth and Market Share Recovery: After facing disruptions, Clorox is focused on regaining market share and stimulating category growth. The company aims for positive low single-digit organic sales growth in the second half of the fiscal year 2026 and a return to historical category growth rates of 2-2.5%. Efforts are particularly noted in areas like the Glad brand and the Professional Products Division (PPD).
-
International Market Expansion and Stability: Clorox's international business has shown growth above the company's sales average. The divestiture of the Argentina business is anticipated to reduce volatility and create more stability and growth opportunities in other parts of the world.
AI Analysis | Feedback
Share Repurchases
- Clorox had $75 million in share repurchases for the quarter ending June 30, 2025.
- Annual share repurchases for fiscal year 2022 were $25 million.
- The company has an authorized open-market share repurchase program of up to $2 billion, which was approved in May 2018 and has no expiration date.
Share Issuance
- Clorox's issuance of common stock for the latest twelve months ending June 30, 2025, was $26 million.
- The average annual issuance of common stock for fiscal years ending June 2021 to 2025 was $33.6 million.
- Share issuance peaked at $103 million in fiscal year 2021.
Outbound Investments
- Clorox divested its Better Health Vitamins, Minerals and Supplements (VMS) business.
- The company also divested its business operations in Argentina.
- Clorox is in the process of settling its Glad joint venture with Procter & Gamble, where it will acquire P&G's 20% stake.
Capital Expenditures
- Clorox's capital expenditures for the latest twelve months ending June 30, 2025, were $220 million.
- Capital expenditures averaged $248.4 million for fiscal years ending June 2021 to 2025.
- The company is investing $500 million over the next few years in transformative technologies and processes, including a new enterprise resource planning (ERP) system and a transition to a cloud-based platform, with these investments commencing in fiscal year 2022.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Clorox Earnings Notes | 12/29/2026 | |
| Is Wall Street Underestimating Clorox Stock's Potential? | 12/12/2025 | |
| 5-Day Rally Sends Clorox Stock Up 9.5% | 11/27/2025 | |
| Clorox Stock: High Cash Flow - Why Not Watch It? | 11/18/2025 | |
| Clorox Stock Drop Looks Sharp, But How Deep Can It Go? | 10/17/2025 | |
| Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/6/2025] | 09/07/2025 | |
| Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/5/2025] | 09/06/2025 | |
| ARTICLES | ||
| Stocks Trading At 52-Week Low | 12/24/2025 | |
| S&P 500 Stocks Trading At 52-Week Low | 12/23/2025 | |
| Could You Be Missing Clorox Stock’s Upside? | 12/12/2025 | |
| Clorox Stock Rockets 9.5% With 5-Day Winning Streak | 11/27/2025 | |
| Is Clorox Stock Poised for a Rally? | 11/12/2025 |
Trade Ideas
Select ideas related to CLX.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02272026 | BRBR | BellRing Brands | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 0.0% | 0.0% | 0.0% |
| 02132026 | STZ | Constellation Brands | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 5.7% | 5.7% | 0.0% |
| 02132026 | KMB | Kimberly-Clark | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 1.9% | 1.9% | -1.7% |
| 02062026 | AVO | Mission Produce | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 1.1% | 1.1% | -2.7% |
| 01022026 | CALM | Cal-Maine Foods | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 12.0% | 12.0% | -7.7% |
| 11142025 | CLX | Clorox | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 24.0% | 24.0% | -6.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 111.08 |
| Mkt Cap | 55.7 |
| Rev LTM | 16,657 |
| Op Inc LTM | 2,691 |
| FCF LTM | 1,772 |
| FCF 3Y Avg | 2,048 |
| CFO LTM | 2,865 |
| CFO 3Y Avg | 2,955 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 1.2% |
| Rev Chg 3Y Avg | 3.2% |
| Rev Chg Q | 2.7% |
| QoQ Delta Rev Chg LTM | 0.7% |
| Op Mgn LTM | 17.7% |
| Op Mgn 3Y Avg | 17.1% |
| QoQ Delta Op Mgn LTM | 0.0% |
| CFO/Rev LTM | 19.0% |
| CFO/Rev 3Y Avg | 18.5% |
| FCF/Rev LTM | 14.6% |
| FCF/Rev 3Y Avg | 14.6% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 55.7 |
| P/S | 3.9 |
| P/EBIT | 20.1 |
| P/E | 27.8 |
| P/CFO | 18.8 |
| Total Yield | 4.8% |
| Dividend Yield | 1.6% |
| FCF Yield 3Y Avg | 4.5% |
| D/E | 0.1 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 4.4% |
| 3M Rtn | 13.0% |
| 6M Rtn | 5.5% |
| 12M Rtn | -6.2% |
| 3Y Rtn | 23.6% |
| 1M Excs Rtn | 5.9% |
| 3M Excs Rtn | 9.7% |
| 6M Excs Rtn | -1.8% |
| 12M Excs Rtn | -24.8% |
| 3Y Excs Rtn | -47.8% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Health and Wellness | 2,485 | 2,532 | 2,427 | 2,980 | 2,749 |
| Household | 1,950 | 2,098 | 1,984 | 1,981 | 1,795 |
| Lifestyle | 1,275 | 1,338 | 1,253 | 1,218 | 1,154 |
| International | 1,162 | 1,181 | 1,180 | 1,162 | 1,023 |
| Corporate and Other | 221 | 240 | 263 | ||
| Total | 7,093 | 7,389 | 7,107 | 7,341 | 6,721 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| International | 1,327 | 1,410 | 1,453 | 1,489 | 1,010 |
| Health and Wellness | 1,124 | 1,184 | 1,275 | 2,043 | 2,145 |
| Lifestyle | 1,110 | 1,091 | 1,035 | 1,011 | 956 |
| Corporate and Other | 1,102 | 1,178 | 1,350 | 879 | 1,292 |
| Household | 1,088 | 1,082 | 1,045 | 912 | 810 |
| Total | 5,751 | 5,945 | 6,158 | 6,334 | 6,213 |
Price Behavior
Price Behavior
| Market Price | $117.43 | |
| Market Cap ($ Bil) | 14.3 | |
| First Trading Date | 03/21/1983 | |
| Distance from 52W High | -19.1% | |
| 50 Days | 200 Days | |
| DMA Price | $112.55 | $115.63 |
| DMA Trend | down | up |
| Distance from DMA | 4.3% | 1.6% |
| 3M | 1YR | |
| Volatility | 26.0% | 23.2% |
| Downside Capture | -62.88 | 29.86 |
| Upside Capture | 15.13 | 3.17 |
| Correlation (SPY) | 1.9% | 21.7% |
CLX Betas & Captures as of 2/28/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.04 | 0.04 | -0.09 | -0.07 | 0.26 | 0.23 |
| Up Beta | 1.00 | 0.82 | 0.71 | 1.00 | 0.33 | 0.43 |
| Down Beta | 1.49 | 0.53 | -0.10 | 0.07 | 0.26 | 0.11 |
| Up Capture | 28% | 71% | 28% | -19% | 5% | 3% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 15 | 29 | 37 | 65 | 125 | 377 |
| Down Capture | -213% | -183% | -98% | -77% | 37% | 39% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 6 | 12 | 24 | 58 | 125 | 373 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLX | |
|---|---|---|---|---|
| CLX | -21.7% | 23.4% | -1.10 | - |
| Sector ETF (XLP) | 6.4% | 14.1% | 0.21 | 64.7% |
| Equity (SPY) | 18.5% | 19.2% | 0.76 | 21.2% |
| Gold (GLD) | 78.4% | 26.1% | 2.20 | 1.7% |
| Commodities (DBC) | 19.7% | 17.1% | 0.89 | 1.5% |
| Real Estate (VNQ) | 5.3% | 16.6% | 0.14 | 45.6% |
| Bitcoin (BTCUSD) | -20.7% | 45.1% | -0.38 | 7.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLX | |
|---|---|---|---|---|
| CLX | -5.3% | 25.0% | -0.23 | - |
| Sector ETF (XLP) | 8.9% | 13.2% | 0.45 | 55.4% |
| Equity (SPY) | 13.9% | 17.0% | 0.65 | 19.3% |
| Gold (GLD) | 23.4% | 17.3% | 1.11 | -0.0% |
| Commodities (DBC) | 11.2% | 19.0% | 0.47 | -8.4% |
| Real Estate (VNQ) | 5.2% | 18.8% | 0.18 | 29.0% |
| Bitcoin (BTCUSD) | 7.7% | 56.8% | 0.36 | 4.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLX | |
|---|---|---|---|---|
| CLX | 1.9% | 23.8% | 0.08 | - |
| Sector ETF (XLP) | 8.2% | 14.7% | 0.43 | 54.5% |
| Equity (SPY) | 15.4% | 17.9% | 0.74 | 22.2% |
| Gold (GLD) | 15.0% | 15.6% | 0.80 | 4.4% |
| Commodities (DBC) | 9.0% | 17.6% | 0.42 | -4.4% |
| Real Estate (VNQ) | 6.5% | 20.7% | 0.28 | 27.7% |
| Bitcoin (BTCUSD) | 66.2% | 66.8% | 1.06 | 2.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/3/2026 | |||
| 11/3/2025 | 1.2% | -4.1% | -3.7% |
| 7/31/2025 | -2.0% | 0.4% | -4.9% |
| 5/5/2025 | -2.4% | -0.2% | -6.3% |
| 2/3/2025 | -7.2% | -7.9% | -6.3% |
| 10/30/2024 | 1.3% | 4.0% | 6.8% |
| 8/1/2024 | 7.4% | 7.6% | 19.0% |
| 4/30/2024 | -5.6% | -4.5% | -12.7% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 15 | 11 |
| # Negative | 11 | 9 | 13 |
| Median Positive | 4.7% | 5.8% | 6.8% |
| Median Negative | -5.6% | -4.5% | -5.5% |
| Max Positive | 9.8% | 14.3% | 24.7% |
| Max Negative | -14.5% | -14.5% | -12.7% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/03/2026 | 10-Q |
| 09/30/2025 | 11/03/2025 | 10-Q |
| 06/30/2025 | 08/08/2025 | 10-K |
| 03/31/2025 | 05/05/2025 | 10-Q |
| 12/31/2024 | 02/03/2025 | 10-Q |
| 09/30/2024 | 10/30/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-K |
| 03/31/2024 | 04/30/2024 | 10-Q |
| 12/31/2023 | 02/01/2024 | 10-Q |
| 09/30/2023 | 11/01/2023 | 10-Q |
| 06/30/2023 | 08/10/2023 | 10-K |
| 03/31/2023 | 05/02/2023 | 10-Q |
| 12/31/2022 | 02/02/2023 | 10-Q |
| 09/30/2022 | 11/01/2022 | 10-Q |
| 06/30/2022 | 08/10/2022 | 10-K |
| 03/31/2022 | 05/02/2022 | 10-Q |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Breber, Pierre R | Trust | Buy | 11242025 | 104.13 | 4,000 | 416,516 | 1,353,678 | Form | |
| 2 | Reynolds, Eric H | EVP - Chief Operating Officer | Direct | Sell | 9082025 | 123.78 | 15,041 | 1,861,847 | 6,711,736 | Form |
| 3 | Breber, Pierre R | Direct | Buy | 5092025 | 136.57 | 4,000 | 546,285 | 546,285 | Form | |
| 4 | Marriner, Kirsten | EVP - Chief People Officer | Direct | Sell | 3122025 | 151.62 | 7,494 | 1,136,251 | 4,099,540 | Form |
| 5 | Marriner, Kirsten | EVP - Chief People Officer | Direct | Sell | 3122025 | 150.00 | 733 | 109,950 | 3,945,750 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.